Literature DB >> 12154776

-to: Pinizzotto M, Castillo E, Fiaux M, Temier E, Gaillard RC, Ruiz J (2001) Paraoxanase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.

A D Hodgkinson, B A Millward, A G Demaine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12154776     DOI： 10.1007/s00125-002-0838-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.

Authors:  L H Canani; S Araki; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

2.  Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.

Authors:  S Araki; Y Makita; L Canani; D Ng; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  2000-12       Impact factor: 10.122

3.  Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

Authors:  D K Sanghera; N Saha; C E Aston; M I Kamboh
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

4.  Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes.

Authors:  M Pinizzotto; E Castillo; M Fiaux; E Temler; R C Gaillard; J Ruiz
Journal:  Diabetologia       Date:  2001-01       Impact factor: 10.122

5.  DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.

Authors:  D K Sanghera; C E Aston; N Saha; M I Kamboh
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

6.  Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes.

Authors:  A E Heesom; M L Hibberd; A Millward; A G Demaine
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

7.  Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.

Authors:  J Ruiz; H Blanché; R W James; M C Garin; C Vaisse; G Charpentier; N Cohen; A Morabia; P Passa; P Froguel
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321
  7 in total
  2 in total

1.  Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.

Authors:  R Calle; M I McCarthy; P Banerjee; E Zeggini; C A Cull; K I Thorne; S Wiltshire; S Terra; D Meyer; J Richmond; J Mancuso; P Milos; D Fryburg; R R Holman
Journal:  Diabetologia       Date:  2006-10-03       Impact factor: 10.122

2.  Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans.

Authors:  Farook Thameem; Xin He; V Saroja Voruganti; Subrata D Nath; Paolo Fanti; John Blangero; Jean W Maccluer; Anthony G Comuzzie; Nedal H Arar; Hanna E Abboud
Journal:  Kidney Blood Press Res       Date:  2009-06-18       Impact factor: 2.687
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.